Magenta Therapeutics, Inc. (NASDAQ:MGTA) Sees Significant Drop in Short Interest
Magenta Therapeutics, Inc. (NASDAQ:MGTA – Get Rating) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,060,000 shares, a drop of 10.9% from the March 31st total of 1,190,000 shares. Currently, 2.4% of the company’s shares are short sold. Based […]
Source: theenterpriseleader.com
